Biochemistry, Genetics and Molecular Biology
Genetic Variation
73%
Germline
55%
Germ Cell
55%
Small Molecule
46%
O-Methyltransferase
46%
Immune Checkpoints
46%
Pharmacogenetics
46%
Drug Resistance
46%
Kinase
46%
Phosphotransferase
46%
Cisplatin
46%
Proton Pump
46%
Esomeprazole
46%
Genetic Divergence
46%
Capecitabine
46%
Single-Nucleotide Polymorphism
20%
Rs4680
11%
Absorption
10%
Gene Deletion
9%
Human Leukocyte Antigen
9%
Gene Amplification
9%
Gene Rearrangement
9%
Immunity
9%
Pharmacokinetics
7%
Genetics
6%
Enzyme
6%
CYP2D6
6%
ABCG2
6%
Drug Interaction
6%
Erlotinib
6%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Phosphotransferase Inhibitor
50%
Drug Resistance
50%
Paclitaxel
46%
Esophagus Cancer
46%
Proton Pump Inhibitor
46%
Capecitabine
46%
Esomeprazole
46%
Non Small Cell Lung Cancer
46%
Cohort Study
46%
Alectinib
46%
Neoplasm
33%
Gefitinib
19%
Trough Level
13%
Effusion
10%
Peroxisome Proliferator Activated Receptor
9%
Malignant Neoplasm
7%
Route of Administration
6%
Drug Interaction
6%
Receptor
6%
Combination Therapy
6%
CYP2D6
6%
Bioavailability
6%
Cytochrome P450 1A1
6%
Erlotinib
6%
ABCG2
6%